Skip to Main Content

Paper Details

Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors.
Clinical Cancer Research
29
2022
advanced cancers, advanced melanoma, cancer, head and neck cancers, patients
Author NameAffiliation
Peter K SorgerHarvard Medical School
  • 1 - 1

Datasets

Release 1.2